240 related articles for article (PubMed ID: 29048669)
1. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
Liu X; Wang Y; Zhao J
Oncol Rep; 2017 Nov; 38(5):3187-3196. PubMed ID: 29048669
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
Kang K; Zhang J; Zhang X; Chen Z
Oncol Rep; 2018 Jan; 39(1):401-410. PubMed ID: 29115540
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2.
Li J; Xu J; Yan X; Jin K; Li W; Zhang R
Oncol Rep; 2018 Jul; 40(1):554-564. PubMed ID: 29781037
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
5. KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.
Du F; Cao T; Xie H; Li T; Sun L; Liu H; Guo H; Wang X; Liu Q; Kim T; Franklin JL; Graves-Deal R; Han W; Tian Z; Ge M; Nie Y; Fan D; Coffey RJ; Lu Y; Zhao X
Theranostics; 2020; 10(16):7335-7350. PubMed ID: 32641995
[No Abstract] [Full Text] [Related]
6. MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
Zhao J; Xu J; Zhang R
Oncol Rep; 2018 Feb; 39(2):633-642. PubMed ID: 29207180
[TBL] [Abstract][Full Text] [Related]
7. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑760 inhibits cell proliferation and invasion of colorectal cancer by targeting the SP1‑mediated PTEN/AKT signalling pathway.
Li X; Ding Y; Liu N; Sun Q; Zhang J
Mol Med Rep; 2017 Dec; 16(6):9692-9700. PubMed ID: 29039575
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of the miR-16-KRAS axis promotes colorectal cancer.
You C; Liang H; Sun W; Li J; Liu Y; Fan Q; Zhang H; Yue X; Li J; Chen X; Ba Y
Sci Rep; 2016 Nov; 6():37459. PubMed ID: 27857191
[TBL] [Abstract][Full Text] [Related]
12. Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer.
Ghazanchaei A; Mansoori B; Mohammadi A; Biglari A; Baradaran B
J Cell Physiol; 2018 Jan; 234(1):769-776. PubMed ID: 30076720
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
Wu L; Shi B; Huang K; Fan G
Oncol Rep; 2015 Nov; 34(5):2797-805. PubMed ID: 26352220
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways.
Zhou F; Nie L; Feng D; Guo S; Luo R
Oncol Rep; 2017 Sep; 38(3):1857-1866. PubMed ID: 28731178
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway.
Zhao Y; Pang D; Wang C; Zhong S; Wang S
Tumour Biol; 2016 Aug; 37(8):11485-93. PubMed ID: 27012554
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3.
Zhang J; Zhang Y; Li X; Wang H; Li Q; Liao X
Mol Med Rep; 2017 Nov; 16(5):7864-7872. PubMed ID: 28944887
[TBL] [Abstract][Full Text] [Related]
18. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.
Zhang Z; Zhong X; Xiao Y; Chen C
Oncol Rep; 2019 Jan; 41(1):619-629. PubMed ID: 30365090
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
Chen M; Lin M; Wang X
Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
